Acazicolcept (ALPN-101) is an experimental dual CD28/ICOS antagonist developed by AbbVie. It appears to be a peptide with 363 residues.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.